Relypsa Inc (RLYP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RLYP | TSHA | PSNL | ||
| Company | Relypsa Inc | Taysha Gene Therapies Inc | Personalis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 31.98 | 5.95 | 14.56 | ||
| High | 31.98 | 6.05 | 14.75 | ||
| Low | 31.98 | 5.57 | 13.11 | ||
| Latest | 31.98 | 5.58 | 13.34 | ||
| Change | -0.01 | -0.38 | -2.05 | ||
| % Change | -0.03% | -6.38% | -13.32% | ||
| Volume | 107 | 1,675,100 | 12,072,399 | ||
| 20-Day Average Volume | 1,769,415 | 4,252,890 | 5,605,485 | ||
| Previous Close | 31.99 | 5.96 | 15.39 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.95 | 6.33 | 13.65 | ||
| 20-Day Raw Stochastic | 62.50% | 14.92% | 54.75% | ||
| 20-Day Relative Strength | 76.83 | 44.46 | 55.96 | ||
| Weighted Alpha | +3.30 | +33.19 | +67.97 | ||
| Today's Opinion | N/A | 40% Buy | 80% Buy | ||
| Previous Opinion | N/A | 64% Buy | 96% Buy | ||
| Last Month's Opinion | N/A | 72% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.06% since 08/25/16 | +3.72% since 07/13/26 | -11.30% since 07/13/26 | ||
| Low | 31.95 on 08/29/16 | 5.31 on 07/14/26 | 13.11 on 07/20/26 | ||
| High | 32.04 on 08/31/16 | 6.27 on 07/16/26 | 16.39 on 07/17/26 | ||
| 1-Month | |||||
| %Chg | +0.47% since 08/01/16 | -13.08% since 06/18/26 | +26.57% since 06/18/26 | ||
| Low | 31.83 on 08/02/16 | 5.31 on 07/14/26 | 9.65 on 06/22/26 | ||
| High | 32.04 on 08/31/16 | 7.12 on 06/30/26 | 16.39 on 07/17/26 | ||
| 3-Month | |||||
| %Chg | +61.03% since 06/01/16 | -13.62% since 04/20/26 | +110.41% since 04/20/26 | ||
| Low | 15.73 on 06/27/16 | 5.17 on 05/20/26 | 4.95 on 04/29/26 | ||
| High | 32.12 on 07/27/16 | 7.30 on 05/06/26 | 16.39 on 07/17/26 | ||
| 6-Month | |||||
| %Chg | +137.59% since 03/01/16 | +20.26% since 01/20/26 | +42.07% since 01/20/26 | ||
| Low | 11.60 on 03/16/16 | 4.03 on 03/30/26 | 4.95 on 04/29/26 | ||
| High | 32.12 on 07/27/16 | 7.30 on 05/06/26 | 16.39 on 07/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,434,910 | 1,603,474 | 1,396,978 | ||
| Shares Outstanding, K | 44,840 | 287,361 | 104,721 | ||
| Annual Sales | 18,550,000 | 9,770,000 | 69,650,000 | ||
| Annual Net Income | -178,720,000 | -109,000,000 | -81,270,000 | ||
| Last Quarter Sales | 5,220,000 | 5,490,000 | 15,470,000 | ||
| Last Quarter Net Income | -83,620,000 | -27,850,000 | -30,030,000 | ||
| 60-Month Beta | 2.19 | 1.17 | 2.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.26 on 05/04/16 | -0.12 on 05/06/26 | -0.29 on 05/07/26 | ||
| Earnings Date | 11/02/16 | 08/11/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||